6533b81ffe1ef96bd12776b8

RESEARCH PRODUCT

Use of stents with sirolimus is significantly associated with a reduction in mortality and cardiovascular morbidity at 6- and 12-months post-PTCA

Manfredi RizzoL CampoloA FrasheriV PerniceG BaroneF ContornoS AmatoCm BarbagalloA NotarbartoloMaurizio Averna

subject

stents sirolimus mortality cardiovascular morbidity
yearjournalcountryeditionlanguage
2006-01-01
10.1016/s1567-5688(06)81617-xhttp://hdl.handle.net/10447/77717